{"date":"2025-09-25","count":19,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-5312-2025-09-25-2340-1fqkmsr","company_id":"5312","company":"寶島科","market":"上櫃","industry":"生技醫療","date":"2025-09-25","time":"23:40:51","subject":"澄清媒體報導","clause":"第53款","fact_date":"2025-09-25","cite_as":"公開資訊觀測站重大訊息：寶島科（5312），2025-09-25 23:40，「澄清媒體報導」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-5312-2025-09-25-1804-12robs7","company_id":"5312","company":"寶島科","market":"上櫃","industry":"生技醫療","date":"2025-09-25","time":"18:04:51","subject":"公告本公司配合檢調單位執行搜索調查","clause":"第19款","fact_date":"2025-09-25","cite_as":"公開資訊觀測站重大訊息：寶島科（5312），2025-09-25 18:04，「公告本公司配合檢調單位執行搜索調查」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4724-2025-09-25-1748-1xcemif","company_id":"4724","company":"宣捷幹細胞","market":"興櫃","industry":"生技醫療","date":"2025-09-25","time":"17:48:07","subject":"公告本公司更換主辦輔導推薦證券商暨協辦輔導推薦證券商因業務考量辭任","clause":"第44款","fact_date":"2025-09-25","cite_as":"公開資訊觀測站重大訊息：宣捷幹細胞（4724），2025-09-25 17:48，「公告本公司更換主辦輔導推薦證券商暨協辦輔導推薦證券商因業務考量辭任」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7729-2025-09-25-1733-arkidq","company_id":"7729","company":"仲恩生醫","market":"興櫃","industry":"生技醫療","date":"2025-09-25","time":"17:33:23","subject":"公告本公司114年第一次現金增資收足股款暨增資基準日","clause":"第44款","fact_date":"2025-09-25","cite_as":"公開資訊觀測站重大訊息：仲恩生醫（7729），2025-09-25 17:33，「公告本公司114年第一次現金增資收足股款暨增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6130-2025-09-25-1725-1391blj","company_id":"6130","company":"上亞科技","market":"上櫃","industry":"生技醫療","date":"2025-09-25","time":"17:25:48","subject":"公告本公司補選董事2席(含獨董1席）","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：上亞科技（6130），2025-09-25 17:25，「公告本公司補選董事2席(含獨董1席）」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6130-2025-09-25-1723-2lkq9k","company_id":"6130","company":"上亞科技","market":"上櫃","industry":"生技醫療","date":"2025-09-25","time":"17:23:12","subject":"公告本公司114年股東臨時會重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：上亞科技（6130），2025-09-25 17:23，「公告本公司114年股東臨時會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6589-2025-09-25-1723-p1h1y8","company_id":"6589","company":"台康生技","market":"上市","industry":"生技醫療","date":"2025-09-25","time":"17:23:00","subject":"本公司註銷限制員工權利新股減資變更登記完成","clause":"第36款","fact_date":"2025-09-25","cite_as":"公開資訊觀測站重大訊息：台康生技（6589），2025-09-25 17:23，「本公司註銷限制員工權利新股減資變更登記完成」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6610-2025-09-25-1714-1q7cguv","company_id":"6610","company":"安成生技","market":"興櫃","industry":"生技醫療","date":"2025-09-25","time":"17:14:43","subject":"公告本公司研發主管任命案","clause":"第11款","fact_date":"2025-09-25","cite_as":"公開資訊觀測站重大訊息：安成生技（6610），2025-09-25 17:14，「公告本公司研發主管任命案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6610-2025-09-25-1712-tr9zep","company_id":"6610","company":"安成生技","market":"興櫃","industry":"生技醫療","date":"2025-09-25","time":"17:12:32","subject":"公告本公司與杜康藥業股份有限公司合併發行新股基準日","clause":"第44款","fact_date":"2025-09-25","cite_as":"公開資訊觀測站重大訊息：安成生技（6610），2025-09-25 17:12，「公告本公司與杜康藥業股份有限公司合併發行新股基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4117-2025-09-25-1701-11vxjjv","company_id":"4117","company":"普生","market":"興櫃","industry":"生技醫療","date":"2025-09-25","time":"17:01:47","subject":"本公司114年現金增資股款催繳公告","clause":"第44款","fact_date":"2025-09-25","cite_as":"公開資訊觀測站重大訊息：普生（4117），2025-09-25 17:01，「本公司114年現金增資股款催繳公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4117-2025-09-25-1700-2klbo9","company_id":"4117","company":"普生","market":"興櫃","industry":"生技醫療","date":"2025-09-25","time":"17:00:36","subject":"公告本公司114年第一次現金增資全體董事放棄認購股數達得認購股數二分之一以上，並洽特定人認購事宜","clause":"第37款","fact_date":"2025-09-25","cite_as":"公開資訊觀測站重大訊息：普生（4117），2025-09-25 17:00，「公告本公司114年第一次現金增資全體董事放棄認購股數達得認購股數二分之一以上，並洽特定人認購事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6634-2025-09-25-1642-1qrc7dd","company_id":"6634","company":"欣耀","market":"興櫃","industry":"生技醫療","date":"2025-09-25","time":"16:42:05","subject":"本公司再次受邀出席2025年第九屆美國波士頓脂肪肝炎藥物開發高峰會，並將於正式大會首日口頭發表SNP-6藥物相關試驗進展","clause":"第30款","fact_date":"2025-10-01","cite_as":"公開資訊觀測站重大訊息：欣耀（6634），2025-09-25 16:42，「本公司再次受邀出席2025年第九屆美國波士頓脂肪肝炎藥物開發高峰會，並將於正式大會首日口頭發表SNP-6藥物相關試驗進展」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7827-2025-09-25-1618-arkidq","company_id":"7827","company":"漢康-KY創","market":"上市","industry":"生技醫療","date":"2025-09-25","time":"16:18:40","subject":"公告本公司114年第一次現金增資收足股款暨增資基準日","clause":"第44款","fact_date":"2025-09-25","cite_as":"公開資訊觀測站重大訊息：漢康-KY創（7827），2025-09-25 16:18，「公告本公司114年第一次現金增資收足股款暨增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1784-2025-09-25-1548-13g3led","company_id":"1784","company":"訊聯","market":"上櫃","industry":"生技醫療","date":"2025-09-25","time":"15:48:16","subject":"衛福部核准本公司與國泰綜合醫院合作之自體脂肪幹細胞治療皮下及軟組織缺損計畫","clause":"第53款","fact_date":"2025-09-25","cite_as":"公開資訊觀測站重大訊息：訊聯（1784），2025-09-25 15:48，「衛福部核准本公司與國泰綜合醫院合作之自體脂肪幹細胞治療皮下及軟組織缺損計畫」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3164-2025-09-25-1508-r5u7d5","company_id":"3164","company":"景岳","market":"上市","industry":"生技醫療","date":"2025-09-25","time":"15:08:54","subject":"本公司受邀參加法人說明會","clause":"第12款","fact_date":"2025-09-26","cite_as":"公開資訊觀測站重大訊息：景岳（3164），2025-09-25 15:08，「本公司受邀參加法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4117-2025-09-25-1502-1bq6a4i","company_id":"4117","company":"普生","market":"興櫃","industry":"生技醫療","date":"2025-09-25","time":"15:02:02","subject":"代子公司普優生技股份有限公司公告取得使用權","clause":"第17款","fact_date":"2025-09-25","cite_as":"公開資訊觀測站重大訊息：普生（4117），2025-09-25 15:02，「代子公司普優生技股份有限公司公告取得使用權」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4117-2025-09-25-1433-1b99kbb","company_id":"4117","company":"普生","market":"興櫃","industry":"生技醫療","date":"2025-09-25","time":"14:33:33","subject":"代子公司普優生技股份有限公司公告取得普生(股)公司部分使用權","clause":"第17款","fact_date":"2025-09-25","cite_as":"公開資訊觀測站重大訊息：普生（4117），2025-09-25 14:33，「代子公司普優生技股份有限公司公告取得普生(股)公司部分使用權」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4117-2025-09-25-1311-isqttc","company_id":"4117","company":"普生","market":"興櫃","industry":"生技醫療","date":"2025-09-25","time":"13:11:30","subject":"公告本公司董事會重要決議事項","clause":"第44款","fact_date":"2025-09-25","cite_as":"公開資訊觀測站重大訊息：普生（4117），2025-09-25 13:11，「公告本公司董事會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1795-2025-09-25-1107-1fqkmsr","company_id":"1795","company":"美時","market":"上市","industry":"生技醫療","date":"2025-09-25","time":"11:07:49","subject":"澄清媒體報導","clause":"第51款","fact_date":"2025-09-25","cite_as":"公開資訊觀測站重大訊息：美時（1795），2025-09-25 11:07，「澄清媒體報導」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}